Adding Lapatinib to Trastuzumab Does Not Lengthen the Lives of Women with HER2+
Adding Lapatinib to Trastuzumab Does Not Lengthen the Lives of Women with Early-Stage, HER2-Positive Breast Cancer
http://www.cancer.net/es/node/31201 |
All times are GMT -7. The time now is 05:39 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021